神经病理性疼痛
伤害
医学
大麻素受体
慢性疼痛
大麻素
药理学
脑源性神经营养因子
受体
神经营养因子
肿瘤坏死因子α
麻醉
脊髓
中枢神经系统
内分泌学
内科学
神经营养素
MAPK/ERK通路
热板试验
内大麻素系统
甩尾试验
大麻素受体2型
坐骨神经
大麻
止痛药
作者
Bismarck Rezende,Gabriel Gripp Fernandes,Vitória Macario de Simas Gonçalves,Gabriela Guedes Nascimento,Kethely Lima Marques,Barbara Conceição Costa Azeredo de Oliveira,Yure Bazilio dos Santos,Maria Eduarda Barros de Andrade,Karine Simões Calumbi,Eduardo Perdigão Maia,Luisa Menezes Trefilio,Fernanda Antunes,Fabrícia Lima Fontes-Dantas,Guilherme Carneiro Montes
出处
期刊:Pharmaceuticals
[Multidisciplinary Digital Publishing Institute]
日期:2025-10-08
卷期号:18 (10): 1508-1508
被引量:1
摘要
Background/Objectives: The expanding focus on novel therapeutic pathways for long-term pain relief has directed interest toward compounds obtained from Cannabis sativa. This study evaluated the antinociceptive potential of cannabigerol-enriched extract (CBG) in models of acute and chronic hypernociception, along with morphological outcomes. Methods: Formalin and hot plate tests were used on male Swiss mice to assess acute oral antinociception. To the chronic pain model, 8-week-old male Wistar rats underwent spinal nerve ligation (SNL), and CBG was administered orally by gavage once daily for 14 days. Results: CBG reduced nociceptive responses in the formalin test and hot plate tests, mainly at a dose of 30 mg/kg, showing antinociceptive activity. CBG attenuated SNL-induced thermal and mechanical hypersensitivity, accompanied by reduced microglial density and spinal morphological changes. Importantly, cannabinoid receptor type 2 (CB2R) signaling contributed to the antinociceptive effects of orally administered CBG, whereas cannabinoid receptor type 1 (CB1R), Brain-Derived Neurotrophic Factor (BDNF), and Tumor Necrosis Factor (TNF) did not appear to play major roles under our experimental conditions. Conclusions: Collectively, these findings support CBG as a promising alternative for chronic pain management.
科研通智能强力驱动
Strongly Powered by AbleSci AI